ASCORERS jSTUVIA
PHARM jFINAL jMN j553 jEXAM jWITH jMULTIPLE jCORRECTLY
jANSWERED jQUESTIONS jALREADY jGRADED jA+ j j|VERIFIED
jFOR jLEARNERS
A jclient jasks jthe jNP jabout jthe jdifferences jin jdrug jeffects jbetween jmen
j and jwomen. jWhat jis jknown jabout jthe jdifferences jbetween jthe
j pharmacokinetics jof jmen jand jwomen?
Question joptions:
Body jtemperature jvaries jbetween jmen jand jwomen.
Muscle jmass jis jgreater jin jwomen.
Percentage jof jfat jdiffers jbetween jgenders.
Proven jsubjective jfactors jexist jbetween jthe jgenders. j j j
,ASCORERS jSTUVIA
A jlaboratory jresult jindicates jthat jthe jpeak jlevel jfor ja jdrug jis jabove jthe
j minimum jtoxic jconcentration. jThis jmeans jthat jthe:
Question joptions:
Concentration jwill jproduce jtherapeutic jeffects
Concentration jwill jproduce jan jadverse jresponse
Time jbetween jdoses jmust jbe jshortened
Duration jof jaction jof jthe jdrug jis jtoo jlong j j j j
A jpotentially jlife-threatening jadverse jresponse jto jangiotensin-converting
j enzyme jinhibitors jis jangioedema. jWhich jof jthe jfollowing jstatements jis
j true jabout jthis jadverse jresponse?
Question joptions:
Swelling jof jthe jtongue jor jhoarseness jare jthe jmost jcommon jsymptoms.
,ASCORERS jSTUVIA
It jappears jto jbe jrelated jto jthe jdecrease jin jaldosterone jproduction.
Presence jof ja jdry, jhacky jcough jindicates ja jhigh jrisk jfor jthis jadverse jresponse.
Because jit jtakes jtime jto jbuild jup ja jblood jlevel, jit joccurs jafter jbeing jon jthe
j drug jfor jabout j1 jweek. j j j j
A jprovider jmay jconsider jtesting jfor jCYP2D6 jvariants jprior jto jstarting
j tamoxifen jfor jbreast jcancer jto:
Question joptions:
Ensure jthe jpatient jwill jnot jhave jincreased jadverse jdrug jreactions jto jthe
j tamoxifen
Identify jpotential jdrug-drug jinteractions jthat jmay joccur jwith jtamoxifen
Reduce jthe jlikelihood jof jtherapeutic jfailure jwith jtamoxifen jtreatment
Identify jpoor jmetabolizers jof jtamoxifen j j j
, ASCORERS jSTUVIA
A jwoman jwho jis jpregnant jand jhas jhyperthyroidism jis jbest jmanaged jby ja
j specialty jteam jwho jwill jmost jlikely jtreat jher jwith:
Question joptions:
Methimazole
Propylthiouracil j(PTU)
Radioactive jiodine
Nothing, jtreatment jis jbest jdelayed juntil jafter jher jpregnancy jends j j j
j ***Propylthiouracil j(PTU)---(Was jcounted jwrong jon jmy jtest, jbut jI jam junable
j to jfind jright janswer jother jthan jthis janswer)***
Absolute jcontraindications jthat jclinicians jmust jconsider jwhen jinitiating
j estrogen jtherapy jinclude:
Question joptions:
PHARM jFINAL jMN j553 jEXAM jWITH jMULTIPLE jCORRECTLY
jANSWERED jQUESTIONS jALREADY jGRADED jA+ j j|VERIFIED
jFOR jLEARNERS
A jclient jasks jthe jNP jabout jthe jdifferences jin jdrug jeffects jbetween jmen
j and jwomen. jWhat jis jknown jabout jthe jdifferences jbetween jthe
j pharmacokinetics jof jmen jand jwomen?
Question joptions:
Body jtemperature jvaries jbetween jmen jand jwomen.
Muscle jmass jis jgreater jin jwomen.
Percentage jof jfat jdiffers jbetween jgenders.
Proven jsubjective jfactors jexist jbetween jthe jgenders. j j j
,ASCORERS jSTUVIA
A jlaboratory jresult jindicates jthat jthe jpeak jlevel jfor ja jdrug jis jabove jthe
j minimum jtoxic jconcentration. jThis jmeans jthat jthe:
Question joptions:
Concentration jwill jproduce jtherapeutic jeffects
Concentration jwill jproduce jan jadverse jresponse
Time jbetween jdoses jmust jbe jshortened
Duration jof jaction jof jthe jdrug jis jtoo jlong j j j j
A jpotentially jlife-threatening jadverse jresponse jto jangiotensin-converting
j enzyme jinhibitors jis jangioedema. jWhich jof jthe jfollowing jstatements jis
j true jabout jthis jadverse jresponse?
Question joptions:
Swelling jof jthe jtongue jor jhoarseness jare jthe jmost jcommon jsymptoms.
,ASCORERS jSTUVIA
It jappears jto jbe jrelated jto jthe jdecrease jin jaldosterone jproduction.
Presence jof ja jdry, jhacky jcough jindicates ja jhigh jrisk jfor jthis jadverse jresponse.
Because jit jtakes jtime jto jbuild jup ja jblood jlevel, jit joccurs jafter jbeing jon jthe
j drug jfor jabout j1 jweek. j j j j
A jprovider jmay jconsider jtesting jfor jCYP2D6 jvariants jprior jto jstarting
j tamoxifen jfor jbreast jcancer jto:
Question joptions:
Ensure jthe jpatient jwill jnot jhave jincreased jadverse jdrug jreactions jto jthe
j tamoxifen
Identify jpotential jdrug-drug jinteractions jthat jmay joccur jwith jtamoxifen
Reduce jthe jlikelihood jof jtherapeutic jfailure jwith jtamoxifen jtreatment
Identify jpoor jmetabolizers jof jtamoxifen j j j
, ASCORERS jSTUVIA
A jwoman jwho jis jpregnant jand jhas jhyperthyroidism jis jbest jmanaged jby ja
j specialty jteam jwho jwill jmost jlikely jtreat jher jwith:
Question joptions:
Methimazole
Propylthiouracil j(PTU)
Radioactive jiodine
Nothing, jtreatment jis jbest jdelayed juntil jafter jher jpregnancy jends j j j
j ***Propylthiouracil j(PTU)---(Was jcounted jwrong jon jmy jtest, jbut jI jam junable
j to jfind jright janswer jother jthan jthis janswer)***
Absolute jcontraindications jthat jclinicians jmust jconsider jwhen jinitiating
j estrogen jtherapy jinclude:
Question joptions: